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SUMMARY 
We showed previously that oligodendrocytes and their 
precursors require continuous signalling by protein 
trophic factors to avoid programmed cell death in cul-
ture. Here we show that three classes of such trophic 
factors promote oligodendrocyte survival in vitro: (1) 
insulin and insulin-like growth factors (IGFs), (2) neu-
rotrophins, particularly neurotrophin-3 (NT -3), and (3) 
ciliary-neurotrophic factor (CNTF), leukemia inhibitory 
factor (LIF) and interleukin 6 (IL-6). A single factor, or 
combinations of factors within the same class, promote 
only short-term survival of oligodendrocytes and their 
precursors, while combinations of factors from differ-
ent classes promote survival additively. Long-term sur-
vival of oligodendrocytes in vitro requires at least one 
INTRODUCTION 
Some vertebrate cells require continuous signalling from 
other cells to avoid programmed cell death (Wyllie et aI., 
1984; Martin et aI., 1988; Krypaniou and Isaacs, 1988; 
Williams et aI., 1990; Koury and Bondurant, 1990; Cohen, 
1991), and some naturally occurring cell deaths in verte-
brates seem to reflect the presence of limiting amounts of 
survival factors (Levi-Montalcini, 1987; Purves, 1988; 
Barde, 1989), It is even possible that all vertebrate cells, 
other than blastomeres (Biggers et aI. , 1971), require such 
survival factors (Raff, 1992), Yet, despite its importance, 
there has been relatively little study of cell survival control 
compared to the great effort devoted to the study of cell 
proliferation control. 
We recently showed that oligodendrocytes and their pre-
cursors require signals from other cells to survive in cul-
ture and that about 50% of newly formed oligodendrocytes 
produced in the developing rat optic nerve normally die, 
apparently as a result of a competition for limiting amounts 
of survival factors (Barres et aI. , 1992), In these studies, 
we found that both platelet-derived growth factor (PDGF) 
and insulin-like growth factors (IGFs) promote the survival 
of oligodendrocyte precursor cells in vitro, but that once 
factor from each class, suggesting that multiple signals 
may be required for long-term oligodendrocyte survival 
in vivo. We also show that CNTF promotes oligoden-
drocyte survival in vivo, that platelet-derived growth 
factor (PDGF) can promote the survival of oligoden-
drocyte precursors in vitro by acting on a novel, very 
high affinity PDGF receptor, and that, in addition to its 
effect on survival, NT -3 is a potent mitogen for oligo-
dendrocyte precursor cells. 
Key words: neurotrophins, programmed cell death, apoptosis, 
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the precursor cells stop dividing and begin to differentiate 
into oligodendrocytes, their specific survival requirements 
change: PDGF no longer promotes their survival, although 
IGFs still do, 
These studies raised several questions . Are IGFs the 
only signalling molecules that promote oligodendrocyte 
survival? Are IGFs sufficient to promote long-term as 
well as short-term survival of oligodendrocytes? Which 
trophic factors regulate oligodendrocyte survival in vivo? 
In the present study, we have extended our observations 
on the control of oligodendrocyte survival. We show that 
the protein signalling molecules that promote oligoden-
drocyte survival in vitro fall into at least three classes. 
Whereas a single trophic factor promotes short-term sur-
vival, at least one factor from each class is required to 
promote long-term oligodendrocyte survival in vitro. We 
also show that one of the survival factors , CNTF, pro-
motes oligodendrocyte survival in vivo, that PDGF pro-
motes the survival of oligodendrocyte precursor cells in 
vitro at concentrations that are more than 200-fold lower 
than those required to stimulate these cells to synthesize 
DNA, and that NT-3 , like PDGF, is a potent mitogen, as 
well as a potent survival factor, for the oligodendrocyte 
cell lineage. 
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MATERIALS AND METHODS 
Animals and materials 
Sprague/Dawley (S/D) rats were obtained from the breeding 
colony of University College London. Recombinant human IGFs 
and mouse LIF were generously provided by Mats Lake of Kabi-
gen and John Heath, respectively. Insulin was purchased from 
Sigma. Recombinant human PDGF-AA and PDGF-BB was pur-
chased from Peprotech (NJ). Recombinant human 11-6 was pur-
chased from R & D Systems, Inc. Recombinant rat CNTF and 
mouse NT-3 were prepared as previously described (Stockli et aI., 
1989; Gotz et aI., 1992). The CG-4 oligodendrocyte precursor 
cell line was provided by J. C. Louis (Louis et aI. , 1992). 
Purification of oligodendrocyte precursor cells 
and oligodendrocytes 
Oligodendrocytes and their precursors (0-2A progenitor cells) 
were each purified from postnatal rat optic nerve by sequential 
immunopanning as described previously (Barres et aI. , 1992). 
Briefly, an optic nerve cell suspension was prepared enzymati-
cally with papain and the cells were passed sequentially over a 
series of Petri dishes coated with the following monoclonal anti-
bodies : anti-RAN-2 (IgG; Bartlett et aI., 1981), the 01 anti-galac-
tocerebroside (GC) antibody (IgM; Sommer and Schachner, 1981 , 
1982), and A2BS (IgM; Eisenbarth et aI., 1979). The purified cells 
- oligodendrocytes from the 01 dish and oligodendrocyte precur-
sor cells from the A2BS dish - were removed with trypsin. 
Cell survival assay 
Approximately S,OOO-IO,OOO purified oligodendrocytes or their 
precursor cells were cultured in 96-well plates (Falcon) in 100 III 
of a serum-free medium, containing Dulbecco's Modified Eagle's 
Medium (DMEM), bovine serum albumin (BSA), selenium, 
putrescine, thryoxine, tri-iodothyronine, transferrin, and proges-
terone (modified from Bottenstein and Sato, 1979, as previously 
described by Lillien and Raff, 1990; B-S medium), and the appro-
priate trophic. factors. When tested individually, none of the com-
ponents of the B-S medium promoted survival except for proges-
terone. In its absence, survival of oligodendrocytes after 3 days 
in culture in the absence of added peptide factors was approxi-
mately half that shown in Table I (that is about 10% instead of 
22%). The B-S medium was prepared with a highly purified, crys-
talline grade of BSA (Sigma, A4161) in order to avoid contami-
nating survival factors. It was important that the DMEM contained 
pyruvate (1 mM), as we found that in its absence nearly all of the 
cells died within the first day or two of culture. The percentage 
of surviving cells was assessed after 3, 7, and 14 days by the MTT 
assay (see below) . All values were normalized to the percentage 
of surviving cells at 12 hours after plating, which represented the 
percentage of cells that survived the purification procedure. This 
initial viability was generally between 8S and 90% and was never 
lower than 80%. 
The survival responses of the purified oligodendrocytes and 
purified oligodendrocyte precursor cells to each of the trophic fac-
tors used (except for NT-3 and PDGF) were indistinguishable, 
because, in the absence of mitogen, the oligodendrocyte precur-
sor cells withdraw from the cell cycle and differentiate into oligo-
dendrocytes within 24-48 hours (Barres et aI., 1992). Thus, except 
for NT-3 and PDGF, we have pooled all of the data and have 
described the purified cells simply as oligodendrocytes. In exper-
iments with NT-3, which, like PDGF but unlike the other factors 
tested, was found to be mitogenic for oligodendrocyte precursor 
cells, survival was assessed on newly formed oligodendrocytes, 
which do not divide in response to NT-3 (see Results) . To pre-
pare newly formed oligodendrocytes, purified oligodendrocyte 
precursor cells were cultured for 24 hours in high concentrations 
of insulin (S Ilg/ml) to allow them to differentiate into oligoden-
drocytes before they were resuspended and tested, as described 
previously (Barres et aI., 1992). In experiments with PDGF, sur-
vival was assessed on purified oligodendrocyte precursor cells. 
MTT survival assay 
The MTT survival assay was performed as described by Mosmann 
(1983). MTT (3-( 4,S-dimethylthiazol-2-yl)-2,S-diphenyl tetra-
zolium bromide; Sigma) was dissolved in PBS at S mg/ml and 
sterilized by passage through a Millipore filter (0.22 Ilm). This 
stock solution was added (10 III to 100 III well) to the cultures 
for I hour at 37°C. Viable cells with active mitochondria cleave 
the tetrazolium ring to form a visible dark blue formazan reaction 
product. The percentage of viable cells in each well was counted 
by bright-field phase microscopy. 
Quantitation of DNA in optic nerves 
The amount of DNA in optic nerves was measured as described 
previously (Barres et aI. , 1992). Briefly, optic nerves were digested 
in a buffer containing TES (Tris-HCI 10 mM, EDT A SO mM, SDS 
0.1 %) and proteinase K (200 Ilg/ml) at SsoC for 36 hours . The 
amounts of DNA in the optic nerve digests were measured using 
the fluorimetric method of LaBarca and Paigen (1980; also see 
Brunk et aI., 1979), which is based on the enhancement of fluo-
rescence seen when the dye bisbenzimidazole (Hoechst 332S8) 
binds to DNA. The DNA values were converted to cell number 
by dividing by 6.6 pg of DNA per cell. 
Propidium iodide labelling of cryostat sections of 
optic nerve 
Postnatal rats were anesthetized with ether and perfused with 4% 
paraformaldehyde. The optic nerves were removed and incubated 
in 4% paraformaldehyde at 4°C overnight and transferred to 30% 
sucrose in PBS until equilibrated. The nerves were frozen in OCT 
and cut into 8 Ilm longitudinal sections with a Bright cryostat. 
The sections were collected onto gelatinized glass microscope 
slides, air dried, post-fixed in 70% ethanol for 10 minutes at 
-20°C, and stained with propidium iodide (4 Ilg/ml) solution in 
MEMlHepes containing DNAse-free RNAse A (100 Ilg/ml) for 
30 minutes at 37°C. The slides were washed three times in PBS 
and mounted in Citifluor (City University, London, UK). 
The number of pyknotic nuclei per section was determined by 
averaging the number of pyknotic cells counted in five optic nerve 
sections per animal. Only clearly condensed or fragmented nuclei 
were counted as pyknotic . Most pyknotic nuclei were between 2 
and 4 Ilm in diameter, which was several times smaller than the 
thickness of the section (8 Ilm) . 
Bromodeoxyuridine (BrdU) incorporation and 
immunofluorescence staining 
To label cells in S phase, BrdU (10 IlM; Boehringer Mannheim), 
which is incorporated into replicating DNA (Gratzner, 1982), was 
added to the culture medium for 24 hours. After fixation with 4% 
paraformaldehyde for 90 seconds at room temperature, and a IS 
minute incubation in SO% goat serum containing 1% BSA and 
100 mM L-Iysine to block non-specific binding, cells were sur-
face-stained, either with monoclonal anti-GC antibody (super-
natant used at 1: 1) followed by fluorescein-coupled goat anti-
mouse IgG3 (Nordic; I: 1 00) or with A2BS antibody (supematant 
diluted 1: I) followed by fluorescein-coupled goat anti-mouse IgM 
(u chain specific, Accurate). Cells were post-fixed in 70% ethanol 
at -20°C for 10 minutes, incubated in 2 N HCI for 10 minutes to 
denature the nuclear DNA, followed by 0.1 M sodium borate, pH 
8.S for 10 minutes. The cells were then incubated in SO% goat 
serum containing 0.4% Triton X-lOO for 30 minutes and labelled 
with monoclonal anti-BrdU antibody (ascites, 1: 100; Magaud et 
aI., 1988), followed by rhodamine-coupled goat anti-mouse IgG 1 
(Nordic, 1: 100). In some experiments, cells were stained with 
rabbit anti-GFAP antiserum (Pruss, 1979; diluted I: 100); in this 
case, the cells were fixed with acid-alcohol for 10 minutes at 
-20°C and blocked with goat serum as above. The anti-GFAP 
antibodies were detected with fluorescein-coupled goat anti-rabbit 
IgG (H+L chain specific, Accurate). The coverslips were mounted 
in Citiflour on glass slides and sealed with nail varnish, examined 
in a Zeiss Universal ftuoresence microscope, and photographed 
using Kodak Tri-X film (ASA 400). 
Glial cell types were identified by their characteristic mor-
phologies and antigenic phenotypes: astrocytes were labeled by 
anti-GFAP antiserum (Pruss, 1979), oligodendrocyte precursor 
cells by A2B5 antibody (Raff et aI., 1983) and oligodendrocytes 
by anti-GC antibody (Ranscht et aI. , 1982). 
Preparation of stably transfected 293 cells that 
secrete CNTF 
The cON A coding for the entire coding region of rat CNTF (600 
bp) was cloned 3' of a cONA fragment coding for the first 20 
amino acids of mouse nerve growth factor, as described previ-
ously (Sendnter et aI., 1992). This construct was cloned into the 
pRcCMV expression vector (inVitroGen). Transfection of the 
human embryonic kidney cell line 293 was performed by the cal-
cium phosphate method and stably transfected clones were 
selected with G418 for neomycin resistance. Single clones were 
picked, grown up and the supematants of these clones screened 
for their ability to support the survival of embryonic day 8 chick 
ciliary neurons. As previously described for mouse 03 embryonic 
stem cells, more than 1000 TU (corresponding to at least I ng of 
CNTF) were detectable per ml of supematant from confluent cul-
tures from these cells, indicating that these cells efficiently syn-
thesized and secreted CNTF. 
Transplantation of cell lines 
293 cells secreting CNTF were transplanted into the brain, as 
described previously for transfected COS cells (Barres et aI., 
1992). The cells were trypsinized in a 75 cm2 flask and washed 
as described above. They were resuspended in I ml of Hepes-
buffered Minimum Eagles's Medium (MEM/Hepes) and spun for 
10 seconds at high speed in an Eppendorf microcentrifuge. The 
pellet was resuspended in MEM/Hepes to a concentration of 1 
million cells per 3 ~1. Under ether anesthesia, 3 ~I of the cell sus-
pension was slowly injected through the right frontal skull into 
the subarachnoid space of postnatal rats, using a 10 ~I Hamilton 
syringe. The rats were killed after 4 days. 
RESULTS 
Effects of insulin and IGFs on oligodendrocyte 
survival in vitro 
To determine the survival effects of different concentrations 
of insulin and IGFs on purified oligodendrocytes, we puri-
fied and cultured the cells in B-S serum-free medium (see 
Materials and methods), and assessed their survival after 3 
days with the MTT assay, as described previously 
(Mosman, 1983; Barres et aI., 1992). In the absence of 
added growth factors, the majority of the cells died within 
3 days with the characteristic morphology of apoptosis 
within 3 days (Table 1). In the presence of plateau con-
centrations of IGF-l, IGF-2, or insulin, about two thirds of 
the cells survived for 3 days (Table 1). The concentration 
that promoted half-maximal survival (the EDso) was about 
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Table 1. Survival of purified oligodendrocytes in culture 
% Survival 
% Surviving relative to 
Factor cells at 3D high insulin 
Nothing 22.4±0.7 0 
Insulin (5 ~g/ml) 65.0±0.7 100 
IGF-I (50 ng/ml) 65.2±1.5 100 
IGF-2 (50 ng/ml) 64.5±1.4 99 
NT-3 (5 ng/ml) 61.6±4.3 92 
CNTF (50 ng/ml) 50.3±1.2 65 
LIF (50 ng/ml) 50.4±2.6 66 
IL-6 (50 ng/ml) 49.6±5.2 64 
Approximately 10,000 purified oligodendrocytes were plated in 
triplicate in 96-well Falcon plates in 100 ~l of B-S medium without 
insulin, containing a plateau concentration of the appropriate factor. After 
3 days of culture, the percentage of cells surv ivi ng in each well was 
determined using the MTT assay (see Materials and methods). ·The results 
shown are means±s.e.m. of at least 3 separate experiments. 
0.8 ng/ml for IGF-l (and truncated-IGF-l, not shown), and 
about 8 ng/ml for IGF-2 (Fig. lA), as expected if both IGFs 
promote survival by binding to IGF-l receptors (Sara and 
Hall, 1990). The ED50 for insulin-induced survival was 
about 20 ng/ml, and the dose-response curve was very 
broad, extending over 2 log units (Fig. lA), suggesting that 
insulin promotes survival by activating at least two recep-
tors, presumably insulin and IGF-l receptors (Sara and 
Hall, 1990). 
Effects of NT-3 on oligodendrocyte survival in 
vitro 
The neurotrophins nerve-growth factor (NGF), brain-
derived growth factor (BDNF), NT-3 and neurotrophin-4 
(NT-4) have been shown to promote the survival of vari-
ous nerve cells (Barde, 1990). We tested NGF, BDNF, and 
NT-3 and found that NT-3, but not NGF or BDNF, pro-
moted oligodendrocyte survival in the absence of other 
trophic factors. Plateau concentrations of NT-3 were almost 
as effective as insulin or IGF-l (Table I) , and, EDso was 
27 pg/ml (Fig. IB). 
Effects of CNTF, LlF and IL-6 on oligodendrocyte 
survival in vitro 
We showed previously that CNTF induces oligodendrocyte 
precursors in culture to express the astrocyte-specific pro-
tein GFAP (Hughes et aI., 1988; Lillien et aI., 1988). As 
shown in Table 1, CNTF is also a survival factor for puri-
fied oligodendrocytes in culture. As CNTF, LIF, and IL-6 
belong to a family of homologous cytokines (Patterson, 
1992), we next studied the effects of LIF and IL-6 on oligo-
dendrocyte survival. Both factors promoted the survival of 
purified oligodendrocytes. Plateau concentrations of CNTF, 
LIF, or 1L-6 promoted the survival of about 50% of the 
purified oligodendrocytes for 3 days, and thus were about 
65% as effective as IGF-l or high concentrations of insulin 
(Table 1). The concentrations that promoted half-maximal 
survival were 10 pg/m] for CNTF, 300 pg/ml for LIF, and 
1.5 ng/ml for IL-6 (Fig. 1 C). 
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Fig. 1. Dose-response curves for seven trophic factors that 
promote oligodendrocyte survival in vitro. Oligodendrocytes were 
purified from postnatal rat optic nerves and cultured In seru~-free 
B-S medium containing different concentratIOns of the trophic 
factor. Survival was assessed after 3 days by the MTI assay and is 
expressed as the means±s.e.m. of three cultures. Three families of 
trophic factors are shown: (A) IGF-l, IGF-2 and InsulIn; (B) NT-
3; (C) CNTF, LIF, and IL-6. In B, DNA synthesis by 
oligodendrocyte precursor cells in response to NT-3 is also shown 
(dashed line). The percentages of cells in each well that . 
incorporated BrdU were determined using immunohistochelTIJstry. 
The survival and DNA synthesis values in this figure are 
expressed as a percent of the plateau survival for each factor; 
unnormalized values are shown in Tables I and 2 and In the other 
Figs. 
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Fig. 2. The effect of increasing the concentration of CNTF in 
the developing optic nerve. Control 293 cells or 293 cells that 
had been stably transfected with a plasmid expression vector 
encoding a secreted form of rat CNTF, were injected into the 
subarachnoid space of postnatal rats at P4, and the optic nerves 
were examined at PS. Values represent the means±s.e.m. of 4 
animals. (A) The number of dead cells per longitudinal section 
of optic nerve (stained with propidium iodide) was determined 
in animals that received no cells, untransfected 293 cells, or 
CNTF-expressing 293 cells. (B) The number of mitotic figures 
per longitudinal section was determined in the three groups of 
animals. (C) The number of cells of each type per optic nerve 
was determined in the three groups of animals by dissociating 
the cells and determining immunohistochemically the 
percentage of astrocytes, oligodendrocyte precursor cells, and 
oligodendrocytes. These immunohistochemical values were 
multiplied by the total number of cells per nerve (determIned by 
DNA measurement) to give the number of each cell type per 
nerve. 
Effect of CNTF on oligodendrocyte survival in vivo 
We previously found that the majority of dead cells in the 
normal developing rat optic nerve are newly formed oligo-
dendrocytes and that delivery of exogenous PDGF could 
decrease this naturally occurring cell death and increase the 
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Fig. 3. The effects of combining survival factops within a class on 
short-term oligodendrocyte survival in culture. The survival of 
purified oligodendrocytes was assessed using the MTT assay after 
three days in culture. In this and the following two figures, plateau 
concentrations of each of the trophic factors in a class were used, 
both individually and in combination, and survival is expressed as 
meansis.e.m. of three cultures. (A) Survival in no protein factors, 
insulin, IGF-l, IGF-2, or all three together. (B) Survival in no 
protein factors, NT-3, BDNF, NGF or all three together. (C) 
Survival in no protein factors, CNTF, UF, IL-6 or all three 
together. 
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number of surviving oligodendrocytes. To determine 
whether CNTF could similarly inhibit normal oligodendro-
cyte death in vivo, we delivered extra CNTF into the devel-
oping rat optic nerve by implanting 293 cells that were 
stably transplanted with a cDNA encoding a secreted form 
of CNTF into the subarachnoid space of P4 rats. After 4 
days, we studied the number of dead cells in frozen sec-
tion of the optic nerve. Before implanting the transfected 
293 cells, we showed that culture medium conditioned by 
them had survival activity, but no mitogenic activity, for 
purified optic nerve oligodendrocyte precursor cells in vitro, 
as assessed by the MTT assay and BrdU incorporation, 
respectively, while medium conditioned by untransfected 
293 cells had neither activity (not shown). 
The average number of dead cells per optic nerve sec-
tion was decreased by about 80% in animals that had 
received injections of 293 cells expressing CNTF, but was 
unaffected in the control animals that received untrans-
fected cells (Fig. 2A). The average number of mitotic fig-
ures per section, however, was similar in control and test 
animals (Fig. 2B). Thus the delivery of CNTF inhibited cell 
death but did not seem to influence cell proliferation in the 
optic nerve. 
The total number of cells, determined by measuring the 
amount of DNA, was increased by about 16,000 cells per 
nerve in the CNTF-treated nerves compared with normal 
or control animals (Fig. 2C) . To determine which cell types 
contributed to this increase, optic nerves were dissociated 
and stained with various cell type-specific antibodies: 
whereas the numbers of GFAP+ type-l astrocytes or 
A2B5+ oligodendrocyte precursor cells were not changed 
by CNTF delivery, the number of GC+ oligodendrocytes 
was increased more than 2-fold (Fig. 2C). (About 5% of 
the oligodendrocyte precursor cells in the CNTF-treated 
animals were GFAP+ versus less than 1 % in control ani-
mals). This increase of about 13,000 oligodendrocytes per 
nerve thus accounted for most of the increase in total 
number of cells per optic nerve determined from the 
amount of DNA. 
Effects of multiple factors on short-term 
oligodendrocyte survival 
Because single factors did not promote 100% survival of 
oligodendrocytes, even for three days (Table I), we inves-
tigated whether combinations of the factors would improve 
short-term survival. The factors fell into three classes: (1) 
insulin, IGF-l and IGF-2, (2) NT-3, BDNF, and NGF, and 
(3) CNTF, UF, and IL-6. Combinations of plateau con-
centrations of two or three factors from within a class did 
not give a significantly better survival than the individual 
factors alone (Fig. 3). The combination of insulin, IGF-I 
and IGF-2, for example, did not promote survival better 
than insulin, IGF-I or IGF-2 alone (Fig. 3A). Similarly, the 
combination of NT-3, BDNF and NGF was not better than 
NT-3 alone (Fig. 3B) and the combination of CNTF, LIF 
and IL-6 did not improve survival over the individual fac-
tors alone (Fig. 3C). 
In contrast, a combination of plateau concentration of 
factors from different classes almost always produced addi-
tive effects on survival (Fig. 4). Insulin plus CNTF, for 
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example, was better than insulin or CNTF alone; insulin 
plus CNTF plus NT-3 was better than any two of these 
alone (Fig. 4A). The same was true for IGF-I, LIF and NT-
3 (Fig. 4B). Surprisingly, although BDNF did not promote 
survival on its own or in combination with insulin, the com-
bination of BDNF plus CNTF (with or without insulin) pro-
moted survival better than CNTF alone: after 7 days in cul-
ture, for instance, the percentage of oligodendrocytes 
surviving in insulin (5 Ilg/ml) was 17.2±2.0, in CNTF (5 
ng/ml) plus insulin was 46.4±1.5, in BDNF (50 ng/ml) was 
16.8±0.8 and in BDNF plus CNTF plus insulin was 
80.l±1.7. 
Effects of multiple factors on long-term 
oligodendrocyte survival in vitro 
Although single factors could promote the short-term sur-
vival (for 3 days) of as many as 70% of purified oligo-
dendrocytes, the percentage of surviving cells rapidly fell 
off with increasing time in culture. No single factor pro-
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Fig. 4. The effects of combining survival factors from different 
classes on short-term oligodendrocyte survival in culture. The 
survival of purified oligodendrocytes was assessed using the MTT 
assay after 3 days in culture. (A) Survival in CNTF, IGF-l , IGF-l 
plus CNTF, or IGF-l plus CNTF and NT-3. (B) Survival in UF, 
insulin, UF plus insulin, or UF plus insulin plus NT-3. Note that 
in this experiment, the purified cells studied were newly formed 
oligodendrocytes and thus were I day older that the purified 
oligodendrocyte precursor cells used in the experiment shown in 
Fig. 3 (see Materials and methods). 
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Fig. 5. The effect& of combining one factor from each of the 
three classes on long-term oligodendrocyte survival in culture. 
The survival of purified oligodendrocytes was assessed using the 
MTT assay after 3, 7 and 14 days of culture. (A) Survival in 
medium containing single trophic factors is compared with the 
survival in medium lacking any of these factors. Results with 
insulin (5 ~g/ml) do not differ significantly from those obtained 
with IGF-l (not shown). (B) Survival in medium containing a 
combination of two factors from different classes. Cc) Survival 
in medium containing a combination of three factors from 
different classes. 
moted the survival of more than about a third of the cells 
for a week or of about 10% of the cells for two weeks, and 
when used alone, NT-3 and IGF-1 promoted longer sur-
vival than CNTF (Fig. SA). 
Combinations of two factors from different classes, but 
not from the same class, promoted longer survival. The 
combination of NT-3 and insulin (or IGF-l) was the most 
effective combination of two factors , promoting the sur-
vival of about 60% of the oligodendrocytes for two weeks 
(Fig. SB). 
About 90-9S % of the oligodendrocytes survived for 2 
weeks or longer, when one factor from each of the three 
classes were combined (Fig. SC). Although we did not 
quantitate the effect, it was apparent that cells cultured for 
1-2 weeks in the presence of multiple trophic factors were 
larger and had more processes than cells grown in single 
factors (Fig. 6) . 
Effects of the three classes of protein survival 
factors on oligodendrocyte precursor DNA 
synthesis and differentiation in vitro 
To determine whether any of the protein factors that pro-
moted oligodendrocyte survival would also influence the 
proliferation of oligodendrocytes or their precursors, we 
tested their ability to induce DNA synthesis using a BrdU 
incorporation assay. As previously demonstrated (Barres et 
aI. , 1992), insulin, IGF-l and IGF-2 did not induce BrdU 
incorporation into purified oligodendrocyte precursor cells. 
The same was true for CNTF, UF, IL-6, NGF, and BDNF 
8 
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(Table 2), regardless of whether or not insulin was present 
(not shown). NT-3, however, did promote BrdU incorpora-
tion into purified oligodendrocyte precursor cells, but only 
in the presence of insulin (Table 2). The concentration that 
promoted half-maximal BrdU incorportation was 4S pg/ml 
(Fig. 1B). Although NT-3 (in the presence of insulin) pro-
duced less BrdU incorporation than PDGF-AA, plateau con-
centrations of the two factors together acted more than addi-
tively (Table 2). Moreover, threshold concentrations of 
PDGF-AA and NT-3 together acted synergistically: PDGF-
AA at 3S0 pg/ml and NT-3 at 10 pg/ml, which individually 
induced 2.6±0.7 and 1.6±0.S percent of oligodendrocyte pre-
cursor cells to incorporate BrdU, respectively, together 
induced 23.2±1.0 percent of the cells to incorporate BrdD. 
To study whether any of these factors influence the 
differentiation of oligodendrocyte precursor cells in vitro, 
we studied their effects on the differentiation of precursor 
cells into either GC+ oligodendrocytes or GFAP+ type-2 
astrocytes. As shown in Table 2, none of the factors were 
required for differentiation into GC+ oJigodendrocytes and 
none of them inhibited thi s differentation, the way that basic 
FGF has been shown to do (Bogler et aI. , 1990; McKinnon 
et aI., 1990). CNTF and UF each induced about S% of the 
purified precursor cells to express GFAP weakly after 24 
hours in culture (not shown; the effect of IL-6 was not 
examined); this response was much weaker than that pre-
viously elicited in the presence of other optic nerve cell 
types (Lillien et aI., 1988; Lillien and Raff, 1990). NT-3 
did not induce GFAP expression (not shown). 
Fig. 6. Morphology of 
oligodendrocytes assayed with MTT 
after 7 days in culture. Purified 
oligodendrocytes were cultured in 
serum-free B-S medium containing 
(A) no added protein factors , (8) 
insulin (5 j.l.g/ml); (C) a combination 
of insulin and CNTF (5 ng/ml), or (D) 
a combination of insulin, CNTF, and 
NT-3 (5 ng/ml). Cells were labelled 
with MTT for I hour. The MTT is 
cleaved by viable cells to form an 
insoluble, dark reaction product. Bar, 
40j.l.m. 
L 
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Table 2. BrdU incorporation and differentiation of 
purified oligodendrocyte precursor cells in culture 
Factor % BrdU+ cells % GC+ cells 
Nothing 0 100 
Insulin (5 J..lg/ml) 0 100 
CNTF (50 ng/ml) 0 100 
LIF (50 ng/ml) 0 100 
TL-6 (50 ng/m l) 0 100 
NGF (100 ng/ml) 0 100 
BDNF (50 ng/ml) 0 100 
NT-3 (5 nglml) 0 100 
NT-3+insulin 15± 1 81±2 
PDGF AA ( 10 ng/ml) 37±2 61±3 
PDGF+NT-3+insulin 71±2 25±1 
PDGF+bFGF (10 ng/ml)+insulin 35±2 3±0.3 
Approximately 10,000 purified oligodendrocyte precursor cells were 
plated in 96-well Falcon plates in 100 J..lI of B-S medium without insulin , 
containing the appropriate factor. After I day of culture, BrdU ( 10 J..lM ) 
was added to each well for 17 hours. The percentages of cells in each well 
that incorporated BrdU or that differentiated into oligodendrocytes were 
determined using immunohistochemistry (see Materials and methods). 
The results shown are means±s.e.m. of 3 cultures. 
Comparison of the concentration of PDGF-AA 
required for cell survival with the concentration 
required for DNA synthesis 
Oligodendrocyte precursor cells express the PDGF alpha-
receptor (Hart et aI., 1989b; Pringle et aI., 1992), which can 
be activated by all three forms of PDGF: PDGF-AA, 
PDGF-BB, and PDGF-AB (Heldin et aI., 1988). Previously, 
we found that PDGF-AA promotes the survival of oligo-
dendrocyte precursors and newly formed oligodendrocytes, 
but not of more mature oligodendrocytes, both in vitro and 
in vivo. In the present study, we compared the effects of 
different concentrations of PDGF-AA on the survival and 
DNA synthesis of purified oligodendrocyte precursor cells 
in culture. Surprisingly, the concentration ofPDGF-AA that 
supported half-maximal survival (EDso) was 8 pg/ml , which 
was more than 200 times lower than the EDso for DNA 
synthesis, which was 1850 pg/ml (Fig. 7 A). When an oligo-
dendrocyte precursor-like cell line, CG-4 (Louis et aI., 
1992), was tested, however, the PDGF dose-response curve 
for DNA synthesis (EDso of 1850 pg/ml) was similar to the 
PDGF dose-response curve for survival (EDso of 800 pg/m!; 
Fig. 7B). For both purified oligodendrocyte precursor cells 
and CG-4 cells, plateau concentrations of PDGF supported 
the survival of about 65% to 100% of the cells for 3 days. 
These findings raised the possibility that there are two types 
of PDGF receptors, a high affinity one that supports the 
survival of oligodendrocyte precursor cells and a lower 
affinity one that supports both the survival and prolifera-
tion of these cells, and that CG-4 cells only express the 
latter receptors, while normal oligodendrocyte precursor 
cells express both. 
To test this possibility further, we studied the ability of 
PDGF-BB to support surival and induce DNA synthesis in 
purified oligodendrocyte precursor cells. As shown in Fig. 
7C, PDGF-BB promoted half-maximal DNA synthesis at 
5,555 pg/ml and half-maximal survival at 700 pg/m I (Fig. 
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Fig. 7. Survival and DNA synthesis responses of oligodendrocyte 
precursor cells and CG-4 cells to varying concentrations of PDGF. 
Oligodendrocyte precursors were purified from postnatal rat optic 
nerves and cultured in serum-free B-S medium containing different 
concentrations of the trophic factor. Survival was assessed after 3 
days by the MTI assay. DNA synthesis was measured after 2 days 
by asssaying BrdU incorporation using immunohistochemistry. The 
results are expressed as the means±s.e.m. of three cultures. All 
survival and DNA synthesis values are expressed as a percentage of 
the plateau value for each factor; unnormalized survival values were 
typically about 65% and unnormalized DNA synthesis values were 
about 40% for the purified precursors and about 95% for the CG-4 
cells. (A) The effect of PDGF-AA on purified oligodendrocyte 
precursor cells. (B) The effect of PDGF-AA on CG-4 cells. (C) The 
effect of PDGF-BB on purified oligodendrocyte precursor cells. 
Table 3. Effects of three mitogens on survival, DNA 
synthesis, and differentiation of purified 
oligodendrocyte precursor cells in culture 
PDGF NT-3 bFGF 
Promotes survival 
of oligodendrocyte precursors Yes Yes No 
of ol igodendrocytes (>2d old) No Yes No 
Promotes DNA synthesis by 
oligodendrocyte precursor cell s 
in high insu lin (5 Jlg/ml) Yes Yes Yes 
without insu lin Yes No No 
Promotes DNA synthesis by 
oligodendrocytes (in high insulin) No No Yes 
Inhibits differentiation of 
oligodendrocyte precursor cell s 
into GC+ oligodendrocytes No No Yes 
The table summarizes observations from the present paper and from 
Barres et al. ( 1992); in all cases, the cells were isolated by sequential 
immunopanning and were greater than 99.95% pure. 
7C). The EDso for PDGF-BB-induced DNA synthesis was 
3 times higher than the ED50 for PDGF-AA-induced DNA 
synthesis, as expected since PDGF-BB has a slightly lower 
affinity for PDGF alpha receptors than does PDGF-AA 
(Heldin et aI., 1988). In contrast, PDGF-BB was about 100 
times less potent in promoting the survival of oligoden-
drocyte precursor cells than PDGF-AA. These results 
suggest that oligodendrocyte precursor cells express a novel 
high affinity form of the PDGF receptor that promotes sur-
vival and prefers PDGF-AA to PDGF-BB by a factor of 
100. 
Although newly formed oligodendrocytes do not divide 
in response to PDGF-AA, they still express PDGF recep-
tors (Hart et aI. , 1989a,b) . To test whether they still express 
the very high affinity PDGF receptor, we studied the abil-
ity of different concentrations of PDGF-AA to promote 
their survival. A concentration of 200 pg/ml supported their 
survival as effectively as a concentration of 50 ng/ml (not 
shown), indicating that they do express the high affinity 
form of the receptor. Because newly formed oligodendro-
cytes do not divide in response to PDGF-AA, binding 
studies will be required to determine whether these cells 
also still express low-affinity receptors. 
DISCUSSION 
Multiple signalling proteins promote the survival 
of oligodendrocytes in culture 
Our findings indicate that IGFs are not sufficient on their 
own to promote long-term survival of oligodendrocytes in 
vitro and suggest that multiple signals are required for 
oligodendrocyte survival in vivo. Long-term survival of 
purified oligodendrocytes in serum-free culture could only 
be achieved by a combination of protein survival factors 
that belong to at least three classes: (1) insulin, IGF-I , and 
IGF-2, (2) neurotrophins, particularly NT-3, and (3) CNTF, 
UF, and IL-6. We have thus identified seven signalling pro-
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teins that can promote oligodendrocyte survival in vitro and 
it seems likely that many more will be discovered. In cul-
ture at least, all three classes of factors seem to promote 
oligodendrocyte survival by inhibiting programmed cell 
death, as without them the cells die with the characteristic 
morphological features of apoptosis (Barres et aI., 1992). 
Many of these factors are found in the developing optic 
nerve, including IGF-l (Hannson et aI., 1989), IGF-2 (Sara 
and Carlsson-Skwarut, 1990), CNTF (Stockli et aI., 1991), 
and possibly NT-3 (Ceccatelli et aI., 1991), where they are 
likely to be present in limiting amounts, as 50% of newly 
formed oligodendrocytes in the developing optic nerve nor-
mally die, and these deaths can be inhibited by delivery of 
exogenous trophic factors, such as PDGF (Barres et aI., 
1992) and, as shown in the present study, CNTF. 
Although the serum-free B-S medium used in the in vitro 
experiments described here contained three non-protein sig-
nalling molecules (thyroxine, tri-iodothyronine, and prog-
esterone), only progesterone promoted oligodendrocyte sur-
vival in vitro, and it did so only weakly (see Materials and 
methods). This survival effect of progesterone is interest-
ing in view of the findings of Baulieu and his colleagues 
that glial cell cultures make progesterone (Jung-Testas et 
aI., 1989a,b) and oligodendrocytes in culture contain prog-
esterone receptors (Jung-Testas et aI. , 1991). 
The activation of either the insulin receptor or the 
IGF-1 receptor promotes oligodendrocyte survival 
We previously found that a high concentration of insulin, 
which is sufficient to activate IGF-l receptors, promotes 
oligodendrocyte survival. Our present results indicate that 
insulin also promotes the survival of oligodendrocytes by 
binding to its own receptors: it promotes half-maximal sur-
vival at 20 ng/ml , which is sufficient to bind to insulin 
receptors but not IGF-l receptors (Sara and Hall, 1990). 
Insulin receptors have previously been shown to be 
expressed by oligododendrocytes and their precursors 
(Baron-vanEvercooren et aI., 1991), as have IGF-l recep-
tors (McMorris et aI., 1986; McMorris and Dubois-Da1cq, 
1988). On other cell types, insulin receptors are thought to 
mediate the various metabolic actions of insulin and are not 
generally thought to promote survival (Sara and Hall , 
1990). It seems unlikely that insulin normally promotes 
oligodendrocyte survival in vivo, as it is not thought to cross 
the blood-brain barrier or to be synthesized in the CNS. 
Our dose-response curves suggest that the survival 
effects of IGF-l and IGF-2, as well as of high concentra-
tions of insulin, are all mediated by IGF-l receptors (Sara 
and Hall, 1990), which probably explains why these fac-
tors are not additive in promoting oligodendrocyte survival. 
None of these factors on their own stimulate DNA synthe-
sis in oligodendrocyte or their precursor cells. As IGF-l 
and IGF-2 are present in the developing and adult CNS 
(Rotwein et aI., 1988; Lievre et aI., 1991; Hannson et aI., 
1989; Sara and Carlsson-Skwarut, 1990), they are likely to 
promote the survival of developing oligodendrocytes in 
vivo. 
CNTF, UF, and IL-S promote oligodendrocyte 
survival 
Although CNTF, UF, and IL-6 each promote the survival 
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of oligodendrocytes and their precursors in vitro, they are 
only about 65 % as effective as high insulin or IGF-l. Sim-
ilar observations have recently been made by others (M. 
Noble, personal communication; Louis et aI., 1993). We 
show here that CNTF can also promote oligodendrocyte 
survival in vivo: the delivery of exogenous CNTF into the 
developing rat optic nerve decreases the number of dead 
oligodendrocytes by 80% and approximately doubles the 
number of oligodendrocytes that develop over the 4 day 
period of the experiment. CNTF and LIF have already been 
shown to support the survival of several types of neurons 
in vitro, including ciliary ganglion neurons and motor neu-
rons (Barbin et aI., 1984; Arakawa et aI., 1990; Sendnter 
et aI., 1991; Martinou et aI., 1992), and the concentrations 
that promote the survival of neurons are similar or identi-
cal to the concentrations that support oligodendrocytes. 
CNTF has also been shown to promote the survival of 
motor neurons in vivo (Sendnter et aI., 1990; Oppenheim 
et aI. , 1991). 
Although CNTF is synthesized by optic nerve astrocytes 
(Stockli et aI., 1991), it is unlikely to be available normally 
to oligodendrocytes in vivo: it lacks a secretory signal 
sequence and is not secreted by cells in vitro (Stockli et aI., 
1989). LIF and IL-6, by contrast, have secretory signal 
sequences and are secreted, but it is not known whether 
they are normally present in white matter or optic nerve. 
LIF is expressed in certain brain regions (Yamamori, 1991), 
however, and astrocytes can secrete IL-6 and LIF in vitro 
(reviewed by Patterson and Fann, 1992). LIF, like CNTF, 
can induce oligodendrocyte precursor cells to express 
GFAP and so the paucity of GFAP+ cells of the oligoden-
drocyte cell lineage in the developing optic nerve (Fulton 
et aI. , 1991) suggests either that sufficient amounts of 
CNTF or LIF are not normally available in vivo, or that 
extracellular-matrix-bound signals that have been shown to 
collaborate with CNTF in inducing stable GFAP expression 
in vitro are not available, even though they are present in 
the nerve (Lillien et aI., 1990). 
CNTF would, however, be expected to be released after 
injury to astrocytes (Rudge et aI., 1985; Lillien et aI., 1988), 
and thus it is likely to promote the survival of oligoden-
drocytes in the injured CNS. Delivery of exogenous CNTF 
into the brain might be able to promote the survi val of 
injured oligodendrocytes in demyelinating diseases, just as 
it promotes motor neuron survival both after axotomy 
(Sendnter et aI., 1990) and in mutant mice with progres-
sive motor neuronopathy (Sendnter et aI., 1992). 
Why are the effects of CNTF, LIF and IL-6 in promot-
ing oligodendrocyte survival not additive? Unlike the case 
of insulin and the IGFs, this finding cannot be explained 
by an action on a common receptor: the EDso for oligo-
dendrocyte survival for each factor closely corresponds 
with the binding affinity for their respective receptors on 
other cell types (Huber et aI., 1992; Hilton and Nicola, 
1992; Van-Snick, 1990), suggesting that CNTF, LIF and 
IL-6 receptors are all present on oligodendrocytes, . Instead, 
the lack of additive effects most likely reflects the sharing 
of a common signal-transducing subunit by the three recep-
tors (Ip et aI., 1992; Taga et aI., 1992), which may there-
fore promote survival by activating the same intracellular 
signalling pathways. 
As in the case of insulin, the broad shape of the LIF 
dose-response curve suggests that LIF may promote sur-
vival by an action on two different receptors. High and low 
affinity binding sites for LIF have recently been reported 
(Hilton and Nicola, 1992), with KdS of about 50 pM and 1 
nM, respectively. The two receptors may be distinguished 
by the presence or absence of one of the the LIF receptor 
subunits. 
Neither CNTF, nor LIF, nor IL-6 induce DNA synthesis 
in purified oligodendrocytes or their precursor cells. This 
contrasts with the recent demonstration by Louis et al. 
(1992) that IL-6 promotes the proliferation of CG-4 cells, 
an oligodendrocyte-precursor cell line. 
NT -3 promotes oligodendrocyte survival and 
oligodendrocyte precursor cell proliferation 
NT -3 promotes the short-term survival of oligodendrocytes 
almost as effectively as high insulin or IGFs and it also 
stimulates DNA synthesis in oligodendrocyte precursor 
cells. To our knowledge, this is the first evidence that CNS 
glial cells respond to neurotrophins . NT -3 promotes the pro-
liferation of neural crest cells (Kalcheim et aI., 1992) and 
the survival of DRG neurons from 8-day-old chick embryos 
(Gotz et aI., 1992), and the EDsos for neuronal and oligo-
dendrocyte survival are nearly identical. 
Of the factors we have tested that have a secretory signal 
sequence, NT-3 is the single most potent oligodendrocyte 
survival factor. It is also the most potent mitogen for oligo-
dendrocyte precursor cells, being about 10 times more 
potent than PDGF in inducing DNA synthesis, although 
NT-3 requires IGFs (or a high concentration of insulin) for 
this effect, whereas PDGF does not. Thus NT-3 may well 
be among the factors that normally act in vivo to promote 
the survival of oligodendrocytes and the survival and pro-
liferation of their precursors. 
But is NT-3 available to oligodendrocytes in vivo? NT-
3 mRNA has been observed by in situ hybridization in glial 
cells in sections of optic nerve and other white matter tracts 
(Ceccatelli et aI., 1991). In that study NT-3 mRNA was 
detected only after colchicine pretreatment and it is not 
clear if this increased the sensitivity of detection or pro-
moted the expression of mRNAs that would not otherwise 
have been expressed. NT-3 mRNA is expressed by neurons 
in many brain regions (Schecterson and Bothwell, 1992; 
Ernfors et aI., 1992), and we have found that neurons pro-
mote both the survival of oligodendrocytes and the prolif-
eration of their precursor cells in the developing optic nerve 
(Barres et aI. , unpublished data; Barres and Raff, 1993). 
Cerebellar interneurons in vitro secrete a non-PDGF mito-
gen for oligodendrocyte precursor cells (Levine, 1989; Gard 
and Pfeiffer, 1990), which may well be NT-3, as cerebel-
lar granule neurons have been shown to make NT-3 mRNA 
(Ernfors et aI., 1992; Schecterson and Bothwell , 1992). 
Thus, NT-3 may be involved in neuron-glial interactions, 
as well as in neuorn-neuron interactions. 
NT-3 is the third mitogen for oligodendrocyte precursor 
cells to be identified. The others are bFGF (Bogler et aI., 
1990) and PDGF (Noble et aI. , 1988; Richardson et aI., 
1988). Interestingly, they all have different effects on cells 
of the oligodendrocyte lineage, as reviewed in Table 3. 
In contrast to NT-3, which on its own promotes oligo-
dendrocyte survival in vitro, BDNF promotes oligodendro-
cyte survival only when combined with CNTF. Similarly, 
chick motorneurons in vitro are not saved by BDNF, but 
are responsive to BDNF in vivo (Oppenheim et aI., 1992). 
It seems that a cell's sensitivity to BDNF is regulated by 
extrinsic factors both in vitro and in vivo. 
PDGF-AA may promote oligodendrocyte 
precursor cell survival by activating a novel high-
affinity receptor 
Perhaps the most surprising finding of the present study is 
that the concentration of PDGF-AA that promotes half-
maximal survival of oligodendrocyte precursor cells is more 
than 200-fold lower than the half-maximal concentration 
that promotes DNA synthesis in these cells. In contrast, the 
EDsos of NT-3 for survival and proliferation of oligoden-
drocyte precursor cells only differs by several-fold. The dra-
matically different dose-response curves for PDGF-induced 
survival and DNA synthesis raises the possibility that there 
are two types of PDGF receptors on oligodendrocyte pre-
cursors: a low-affinity receptor that mediates both prolifer-
ation and survival and a high affinity receptor that medi-
ates survival only. Two of our observations are consistent 
with this possibility. First, the high affinity survival 
response is not seen with PDGF-BB, even though PDGF-
BB binds almost as well to the PDGF alpha-receptor 
(Heldin et aI., 1988) and is almost as effective as PDGF-
AA in inducing DNA synthesis in these cells. Second, the 
PDGF-AA dose-response for survival promotion and DNA 
synthesis induction are not very different when the CG-4 
oligodendrocyte precursor cell line is studied. The simplest 
interpretation of these results is that normal oligodendro-
cyte precursor cells express two PDGF receptors, one with 
high affinity that promotes survival and prefers PDGF-AA 
to PDGF-BB by a factor of 100 or so, and one with lower 
affinity that promotes both survival and proliferation and 
prefers PDGF-AA to PDGF-BB by a factor of only 3, and 
that CG-4 cells appear to have mainly the low affinity 
receptor. 
Previously, oligodendrocyte precursor cells were shown 
to express PDGF alpha-receptor protein (Hart et aI., 
1989a,b) and mRNA (Pringle et aI., 1992), but not PDGF 
beta-receptors. While, these studies did not exclude the pos-
sible presence of small numbers of beta-receptors, the pres-
ence of both alpha- and beta-receptors could not account 
for our observations, as PDGF-AA does not bind to PDGF 
beta-receptors (Held in et aI., 1988). Thus, our data suggest 
that oligodendrocyte precursor cells express two forms of 
the PDGF alpha-receptor, a standard alpha-receptor and a 
novel, very high affinity receptor, the nature of which is 
unknown. 
The presence on newly formed oligodendrocytes and 
their precursors of high affinity PDGF receptors that medi-
ate survival but not proliferation responses to PDGF could 
have important implications for the behavior of these cells 
in vivo. A low concentration of PDGF in vivo, for exam-
ple, could promote the survival of the oligodendrocyte pre-
cursors without promoting their proliferation. This could 
help to explain why oligodendrocyte precursor cells in the 
adult optic nerve express PDGF alpha-receptors (Pringle et 
aI., 1992) but seem to divide only slowly (G. Wolswijk, 
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personal communication; ffrench-Constant and Raff, 1986): 
concentrations of PDGF may be low in the adult nerve or 
the adult precursor cells may preferentially express the 
high-affinity form of the PDGF receptor. Such receptors 
could also explain the failure of newly formed oJigoden-
drocytes to divide in response to PDGF, even though they 
continue to express PDGF alpha-receptors for a day or more 
(Hart et aI., 1989b) and the receptors can still be activated 
by PDGF so as to increase intracellular Ca2+ (Hart et aI., 
1989a) and nuclear fos expression (Hart et aI., 1992) and 
to promote cell survival (Barres et aI., 1992; and this paper); 
while this may reflect the presence of a downstream block 
to proliferation, as previously suggested (Hart et aI., 1989a, 
1992), it may instead reflect the selective loss of the low-
affinity form of the PDGF receptor, which mediates pro-
liferation. 
Can long-term survival of any cell type be 
achieved by a single trophic factor? 
Our results indicate that NT-3, CNTF, and IGF-l can act 
together to promote the long-term survival of the majority 
of oligodendrocytes in vitro. These findings are strikingly 
similar to those of Arakawa et al. (1990), who found that 
multiple factors collaborate to promote the long-term sur-
vival of enriched chick embryonic motoneurons in vitro: 
FGF and CNTF individually promoted survival of about 
half of the motoneurons, whereas together they saved 100% 
of them. These authors also found that, in contrast to the 
oligodendrocytes, IGF-l had little effect on its own, 
although it acted additively with either CNTF or FGF to 
save motorneurons. In the case of motoneurons, it is not 
clear if the additive effects of FGF and CNTF are explained 
by the presence of subsets of motoneurons with different 
survival requirements or by the combined action of both 
factors on the same cell. In the case of oligodendrocytes, 
which are probably more homogeneous than motorneurons, 
it is unlikely that the additive effects of NT -3, CNTF, and 
IGF-l are explained by the presence of oligodendrocyte 
subsets. 
Our failure so far to find a single factor that is able on 
its own to promote long-term oligodendrocyte survival in 
vitro does not mean that such a factor does not exist. On 
the other hand, among cells that have been shown to require 
survival factors, we are not aware of any example where a 
single signalling molecule on its own permits long-term sur-
vival in culture. Motoneurons, for example, require multi-
ple factors (as described above), including laminin 
(Dohrman et aI., 1986; Sendnter et aI., 1991), some DRG 
neurons require insulin, progesterone, and serum, in 
addition to NGF (Bottenstein et aI., 1980), and purified reti-
nal ganglion cells require a combination of at least four sig-
nalling proteins (unpublished observations). Although there 
are few examples of primary cell types that have been puri-
fied sufficiently to assess adequately their survival require-
ments in vitro, it seems possible that all cells require mul-
tilple survival factors for long-term survival. 
The identification of three classes of extracellular sig-
nalling proteins that additively promote oligodendrocyte 
survival raises several questions. Do all three classes of fac-
tors normally promote oligodendrocyte survival in vivo, and 
if so, which members of each class are most important? Are 
294 B. A. Barres and others 
there more classes? Which classes of survival factors 
depend on axons for their production or release? Does the 
existence of three classes of survival factors imply that there 
are at least three intracellular signalling pathways that can 
act to promote survival, and, if so, where do the pathways 
converge? 
We thank R. Kolbeck and Y. A. Barde for supplying the recom-
binant neurotrophins, M. Lake at Kabi PharmacialKabigen in 
Stockholm for supplying the recombinant human IGFs and J. 
Heath for supplying the recombinant mouse UF, and J. C. Louis 
for providing the CG-4 cell line. B. A. Barres is supported by a 
fellowship from the US National Multiple Sclerosis Society and 
is a Schering-Plough Fellow of the Life Sciences Research Foun-
dation. 
REFERENCES 
Arakawa, Y., Sendtner, M. and Thoenen, H. (1990). Survival effect of 
ciliary neurotrophic factor (CNTF) on chick embryonic motoneurons in 
culture: comparision with other neurotrophic factors and cytokines. 1. 
Neurosei.l0,3507-3515. 
Barbin, G., Manthorpe, M. and Varon, S. (1984). Purification of the chick 
eye ciliary neurotrophic factor. 1. Neuroehem. 43.1468-1478. 
Barde, Y. A. (1989). Trophic factors and neuronal survival. Neuron 2, 
1525-34. 
Barde, Y. A. (1990). The nerve growth family. Prog. Growth Factor Res. 2, 
237-48. 
Barde, Y. A., Edgar, D. and Thoenen, H. (1982). Purification of a new 
neurotrophic factor from mammalian brain. EMBO 1.1,549-553. 
Baron-Van Evercooren, A., Olichon-Berthe, C., Kowalski, A., Visciano, 
G. and VanObberghen, E. (1991). Expression of IGF-I and insulin 
receptor genes in the rat central nervous system: a developmental , 
regional, and cellular analysis. 1. Neurosei. Res. 28, 244-253. 
Barres, B. A., Hart, I. K, Coles, H. S. R., Burne, J. F. Voyvodic, J. T., 
Richardson, W. D. and Raff, M. C. (1992) . Cell death and control of cell 
survival in the oligodendrocyte lineage. Cell 70. 31-46. 
Barres, B. A. and Raff M. C. (1993). Proliferation of oligodendrocyte 
precursor cells depends on electrical activity in axons. Nature 361, 258-
260. 
Bartlett, P. F., Noble, M. D., Pross, R. M., Raff, M. c., Rattray, S. and 
Williams, C. A. (1981). Rat neural antigen-2 (RAN-2): A cell surface 
antigen on astrocytes, ependymal cells , Muller cells and lepto-meninges 
defined by a monoclonal antibody. Brain Res. 204, 339-351. 
Biggers, J. D., Whitten, W. K and Whittingham, D. G. (1971). The 
culture of mouse embryos in vitro. In Methods in Mammalian 
Embryology (ed. J. C. Daniel), pp. 86-116. San Francisco: Freeman. 
Bogler, 0., Wren, D., Barnett, S., Land, H. and Noble, M. (1990). 
Cooperation between two growth factors promotes extended self renewal 
and inhibits differentiation of 0Iigodendrocyte-type-2 astrocyte (O-2A) 
progenitor cells. Proe. Natl. Aead. Sci. USA 87, 6368·6372. 
Bottenstein, J. K and Sato, G. H. (1979). Growth of a rat neuroblastoma 
cell line in serum-free supplemented medium. Proe. Natl. Aead. Sei. USA 
76,514-517. 
Bottenstein, J. E., Skaper, S. D., Varon, S. S. and Sato, G. H. (1980). 
Selective survival of neurons from chick embryo sensory ganglionic 
dissociates utilizing serum-free supplemented medium. Exp. Cell Res. 
125,183-190. 
Bronk, C. F., Jones, KC. and James, T. W. (1979). Assay for nanogram 
quantities of DNA in cellular homogenates. Analyt. Bioehem. 92, 497-
500. 
Ceccatelli, S., Ernfors, P., Villar, M. J. Persson, H. and HokfeIt, T. 
(1991). Expanded distribution of mRNA for nerve growth factor, brain-
derived neurotrophic factor, and neurotrophin 3 in the rat brain after 
colchicine treatment. Proe. Natl. Aead. Sei. USA 88, 10352-10356. 
Cohen, J. J. (1991). Programmed cell death in the immune system. Adv. 
Immunol. 50, 55-85. 
Dohrmann, U., Edgar, D. and Thoenen, H. (1986). Muscle-derived 
factors that support survival and promote fiber outgrowth from embryonic 
chick spinal motor neurons in culture. Dev. Bioi. 118, 209-221. 
Eisenbarth, G. S., Walsh, F. S. and Nirenburg, M. (1979). Monoclonal 
antibodies to a plasma membrane antigen of neurons. Proc. Natl. A cad. 
Sei. USA 76, 4913-6. 
Ernfors, P., Merlio, J. P. and Persson, H. (1992). Cells expressing mRNA 
for neurotrophins and their receptors during embryonic rat development. 
Eur. 1. Neurosei. 3, 953-961. 
ffrench-Constant, C. and Raff, M. C. (1986). Proliferating bipotential 
glial progenitor cells in adult rat optic nerve. Nature 319, 499-502. 
Fulton, B. P., Burne, J. F. and Raff, M. C. (1991). Glial cells in the rat 
optic nerve: The search for the type-2 astrocyte. Ann. NY Aead. Sei. 633, 
27-34. 
Gard, A. L. and Pfeiffer, S. K (1990). Two proliferative stages of the 
oligodendrocyte lineage · under different mitogenic control. Neuron 5, 
615-625. 
Gotz, R, Kolbeck, R, Lottspeich, F. and Barde, Y. A. (1992). Production 
and characterization of recombinant mouse neurotrophin-3. Eur. 1. 
Bioehem. 204, 745-749. 
Gratzncr, H. G. (1982). Monoclonal antibody to 5-bromo- and 5-
iododeoxyuridine:a new reagent for detection of DNA replication. 
Science 318, 474-475. 
Hannson, H. A., Holmgren, A., Norstedt, G. and Rosell, B. (1989). 
Changes in the distribution of insulin-like growth factor T, thioredoxin , 
thioredoxin reductase and ribonucleotide reductase during the 
development of the retina. Exp. Eye Res. 48, 411-420. 
Hart, I. K, Richardson, W. D., Bolsover, S. Rand Raff, M. C. (l989a). 
PDGF and intracellular signaling in the timing of oligodendrocyte 
differentiation. 1. Cell Bioi. 109, 3411-17. 
Hart, I. K, Richardson, W. D., Heldin, C.-H., Westermark, B. and Raff, 
M. C. (1989b). PDGF receptors on cells of the 0Iigodendrocyte-type-2 
astrocyte (O-2A) cell lineage. Development 105, 595-603. 
Hart, I. K, Richardson, W. D. and Raff, M. C. (1992). PDGF increases 
the expression of fos and jun in newly formed oligodendrocytes that have 
become resistant to the mitogenic effect of PDGF. Glia 6,310-313. 
Heldin, C. H., Backstrom, G., Ostman, A., Hammacher, A., 
Ronnstrand, L., Rubin, K., Nister, M. and Westermark, B. (1988). 
Binding of different dimeric forms of PDGF to human 
fibroblasts:evidence for two separate receptor types. EMBO 1. 7, 1387-
1393. 
Hilton, D. J. and Nicola, N. A. (1992). Kinetic analyses of the binding of 
leukemia inhibitory factor to receptor on cells and membranes in 
detergent solution. 1. Bioi. Chem. 267, 10238-47. 
Huber, J., Thoenen, H. and Sendtner, M. (1992). Characterisation of a 
high and low affinity receptor for CNTF. Soc. Neurosei. Abstr. 276.1. 
Hughes, S. M., Lillien, L. K, Raff, M. c., Rohrer, H. and Sendtner, M. 
(1988). Ciliary neurotrophic factor induces type-2 astrocyte 
differentiation in culture. Nature 335, 70-73. 
lp, N. Y., Nye, S. H., BouIton, T. G., Davis, S., Taga, T., Li, y" Birren, S, 
J. and Yancopoulus, G. D. (1992). CNTF and LIF act on neuronal cells 
via shared signalling pathways that involve the IL-6 signal transducing 
receptor component gp130. Cell 69, 1121-32. 
Jung-Testas, I., Hu, Z. Y., Baulieu, K K and Robel, P. (1989a). Steroid 
synthesis in rat brain cell cultures. 1. Steroid Biochem. 34, 199-204. 
Jung-Testas, I., Hu, Z. Y., Baulieu, K K and Robel, P. (l989b). 
Neurosteroids: biosynthesis of pregnenolone and progesterone in primary 
cultures of rat glial cells. Endoerinol. 125, 2083-2091. 
Jung-Testas, I., Renoir, J. M., Gasc, J. M. and Baulieu, K E. (1991) . 
Estrogen-inducible progesterone receptor in primary cultures of rat glial 
cells. Exp. Cell Res. 193, 12-19. 
KaIcheim, c., Carmeli, C. and Rosenthal, A. (1992). Neurotrophin 3 is a 
mitogen for cultured neural crest cells. Proe. Natl. Aead. Sei. USA 89, 
1661-1665. 
Koury, M. J. and Bondurant, M. C. (1990). Erythropoeitin retards DNA 
breakdown and prevents programmed cell death in erythroid progenitor 
cells. Science 248, 378-81. 
Krypianou, N. and Issacs, J. T. (1988). Activation of programmed cell 
death in the ventral prostate after castration. Endocrinol. 122,552-562. 
Levi-Montalcini, R (1987). The nerve growth factor: 35 years later. EM BD 
1.6,1145-1154. 
Levine, J. M. (1989) . Neuronal influences in glial progenitor cell 
development. Neuron 3, 103-113. 
Lievre, C. A., Stahlbom, P. A. and Sara, V. R. (1991). Expression of IGF-
I and -2 mRNA in the brain and craniofacial region of the rat fetus. 
Development 111, 105-115. 
Lillien, L. K, Sendtner, M., Rohrer, H., Hughes, S. M. and Raff, M. C. 
r 
(1988). Type-2 astrocyte development in rat brain cultures is initiated by 
a CNTF-like protein produced by type I astrocytes. Neuron 1,485-494. 
Lillien, L. E. and Raff, M. C. (1990). Analysis of the cell-cell interactions 
that control type-2 astrocyte development in vitro. Neuron 4, 525-534. 
Lillien, L. E., Sendtner, M. and Raff, M. C. (1990). Extracellular matrix-
associated molecules collaborate with ciliary neurotrophic factor to 
induce type-2 astrocyte development. J. Cell BioI. 111, 635-644. 
Louis, J. C., Magal, E., Muir, D., Manthorpe, M. and Varon, S. (1992). 
CG-4, a new bi-potential glial cell line from rat brain, is capable of 
differentiation in vitro into either mature oligodendrocytes of type-2 
astrocytes. J. Neurosci. Res. 31, 193-204. 
Louis, J. c., Magal, E., Takayama, S. and Varon, S. ( 1992). Differential 
effects of CNTF, UF, and IL-6 on 0Iigodendrocyte-type-2 astrocyte 
progenitor cells. Soc. Neurosci. Abstr. 467.10. 
Louis, J. C., Magal, E., Takayama, S. and Varon, S. (1993). CNTF 
protection of oligodendrocytes against natural and tumor necrosis factor-
induced death. Science 259, 689-692. 
Maguad, J. P., Sargent, I. and Mason, D. Y. (I988). Detection of human 
white cell proliferative responses by immunoenzymatic measurement of 
bromodeoxyuridine uptake. J. Immunol. Meth. 106,95-100. 
Martin, D. P., Schmidt, R. E., DiStefano, P. S., Lowry, O. H., Carter, J. 
G. and Johnson, E. M., Jr (1988). Inhibitors of protein synthesis and 
RNA synthesis prevent neuronal death caused by nerve growth factor 
deprivation. J. Cell Bioi. 106, 829-844. 
Martinou, J. c., Martinou, I. and Kato, A. C. (1992). Cholinergic 
differentiation factor (CDF/UF) promotes survival of isolated rat 
embryonic motoneurons in vitro. Neuron 8, 737-744. 
McKinnon, R. D., Matsui, T., Dubois-DaIcq, M. and Aaronson, S. A. 
(1990). FGF modulates the PDGF-driven pathway of oligodendrocyte 
development. Neuron 5, 603-614. 
McMorris, F. A. and Dubois-DaIcq, M. (1988). Inuslin-like growth factor 
I promotes cell proliferation and oligodendroglial commitment in rat glial 
progenitor cells developing in vitro. J. Neurosci. Res. 21, 199-209. 
McMorris, F. A., Smith, T. M., DeSalvo, S. and Furlanetto, R. W. 
(1986). Insulin-like growth factor I1somatomedin C: a potent inducer of 
oligodendrocyte development. Proc. Natl. Acad. Sci. USA 83, 822-826. 
Mosmann, T. (1983). Rapid colorimetric assay for cellular growth and 
survival: application to proliferation and cytotoxicity assays. J. Immunol. 
Meth. 65,55-63. 
Noble, M., Murray, K, Stroobant, P., Waterfield, M. D. and Riddle, P. 
(1988). PDGF promotes division and motility and inhibits premature 
differentiation of the 0Iigodendrocyte-type-2 astrocyte progenitor cell. 
Nature 333, 560-562. 
Oppenheim, R. W., Prevette, D., Qin-Wei, Y., Collins, F. and 
MacDonald, J. (I 991). Control of embryonic motoneuron survival in 
vivo by ciliary neurotrophic factor. Science 251, 1616-1618. 
Oppenheim, R. W., Qin-Wei, Y., Prevette, D. and Van, Q. (I 992). Brain-
derived neurotrophic factor rescues developing avian motoneurons from 
cell death. Nature 360, 755-757. 
Patterson, P. H. (1992). The emerging neuropoietic cytokine family. Curr. 
Opin. Neurobiol. 2, 94-97. 
Patterson, P. H. and Fann, M. J. (1992). Further studies of the distribution 
ofCDF/UFmRNA. CibaFdn. Sym.167, 124-140. 
Pringle, N., Mudhar, H. S., Collarini, E. J. and Richardson, W. D. 
(1992). Expression of PDGF-alpha receptors in the rat CNS appears to be 
restricted to glial cells of the oligodendrocyte lineage. Development 115, 
535-55l. 
Pruss, R. (1979). Thy-I antigen on astrocytes in long-term cultures of rat 
central nervous system. Nature 303, 390-396. 
Purves, D. (1988). Body and Brain, A Trophic Theory of Neural 
Connections. Cambridge, MA: Harvard. 
Raff, M. C. (1992). Social controls on cell survival and death: an extreme 
view. Nature 356, 397-400. 
Raff, M. c., Miller, R. H. and Noble, M. (1983). A glial progenitor cell that 
develops in vitro into an astrocyte or an oligodendrocyte depending on 
culture medium. Nature 303,390-396. 
Multiple signals for oligodendrocyte survival 295 
Ranscht, B., Clapshaw, P. A., Price, J., Noble, M. and Seifert, W. (1982). 
Development of oligodendrocytes and Schwann cells studied with a 
monoclonal antibody against galactocerebroside. Proe. Natl. Aead. Sei. 
USA 79, 2709-2713. 
Richardson, W. D., eringle, N., Mosley, M. J., Westermark, B. and 
Dubois-DaIcq, M. (1988). A role for platelet-derived growth factor in 
normal gliogenesis in the central nervous system. Cell 53, 309-319. 
Rotwein, P., Burgess, S. K, Milbrandt, J. D. and Krause, J. (1988). 
Differential expression of insulin-like growth factor genes in rat central 
nervous system. Proe. Natl. Acad. Sci. USA 85, 265-269. 
Rudge, J. S., Manthorpe, M. and Varon, S. (1985). The output of 
neuronotrophic and neurite-promoting agents from rat brain astroglial 
cells: a microculture method for screening potential regulatory molecules. 
Dev. Brain Res. 19, 161-172. 
Sara, V. R. and Carlsson-Skwirut, C. (1990). The role of the insulin-like 
growth factors in the central nervous system: biosynthesis and biological 
role. In Growth Factors: From Genes to Clineal Application, (ed. V. R. 
Sara), pp. 179-191. New York: Raven Press. 
Sara, V. R. and Hall, K (1990). Insulin-like growth factors and their 
binding proteins. Physiol. Rev. 70, 591-614. 
Schecterson, L. C. and Bothwell, M. (1992). Novel roles for neurotrophins 
are suggested by BDNF and NT-3 mRNA expression in developing 
neurons. Neuron 9, 449-463. 
Sendnter, M., Arakawa, Y., Stockli, K A., Kreutzberg, G. W. and 
Thoenen, H. (1991). Effect of ciliary neurotrophic factor (CNTF). on 
motoneuron survival. J. Cell Sei. Suppl. 15, 103-109. 
Sendtner, M., Kreutzberg, G. W. and Thoenen, H. (1990). Ciliary 
neurotrophic factor prevents the degeneration of motor neurons after 
axotomy. Nature 345, 440-441. 
Sendtner, M., Schmalbruch, H., Stockli, K A., Corroll, P., Kreutzberg, 
G. W. and Thoenen, H. (1992). Ciliary neurotrophic factor prevents 
degeneration of motor neurons in mouse mutant progressive motor 
neuronopathy. Nature 358, 502-504. 
Sommer, I. and Schachner, M. (1981). Monoclonal antibodies (01 to 04) 
to oligodendrocyte cell surfaces: an immunocytochemical study in the 
central nervous system. Dev. Bioi. 83, 311-327. 
Sommer, I. and Schachner, M. (1982). Cells that are 04-antigen positive 
and 01- negative differentiate into Ol-positive oligodendrocytes. 
Neurosei. Let. 29, 183-188. 
Stockli, K A., Lillien, L. E., Noher-Noe, M., Breitfeld, G., Hughes, R. A., 
Raff, M. C., Thoenen, H. and Sendnter, M. (1991). Regional 
distribution, developmental changes, and cellular localization of CNTF-
mRNA and protein in the rat brain. J. Cell Bioi. 115, 447-459. 
Stockli, K A., Lottspeich, F., Sendnter, M., Masiakowski, P., Carroll, 
P., Gotz, R., Lindholm, D. and Thoenen, H. (1989). Molecular cloning, 
expression and regional distribution of rat ciliary neurotrophic factor. 
Nature 342, 920-923. 
Taga, T., Narazaki, M., Yasukawa, K., Saito, T., Miki, D., Hamaguchi, 
M., Davis, S., Shoyab, M., Yancopoulos, G. D. and Kishimoto, T. 
(1992). Functional inhibition of hematopoietic and neurotrophic 
cytokines by blocking the interleukin 6 signal transducer gp 130. Proe. 
Nail. Aead. Sei. USA 89, 10998-1100l. 
Van Snick, J. (1990). Interleukin-6: An overview. Ann. Rev. Immunol. 8, 
253-278. 
Williams, G. T., Smith, C. A., Spooncer, E., Dexter, T. M. and Taylor, D. 
R. (1990). Haemopoietic colony stimulating factors promote cell survival 
by suppressing apoptosis. Nature 343, 76-78. 
Wyllie, A. H., Morris, R. G., Smith, A. L. and Dunlop, D. (1984). 
Chromatin cleavage in apoptosis: association with condensed chromatin 
morphology and dependence on macro molecular synthesis. J. Pathol. 
142,67-77. 
Yamamori, T. (1991). Localization of cholinergic differentiation 
factor/leukemia inhibitory factor mRNA in the rat brain and peripheral 
tissues. Proe. Natl. Aead. Sei. USA 88, 7298-7302. 
(Accepted 2 March 1993) 
